Essential role for caspase 8 in T-cell homeostasis and T-cell-mediated immunity

  1. Leonardo Salmena1,2,3,
  2. Benedicte Lemmers1,2,3,
  3. Anne Hakem1,2,3,
  4. Elzbieta Matysiak-Zablocki1,2,3,
  5. Kiichi Murakami2,3,
  6. P.Y. Billie Au1,2,3,
  7. Donna M. Berry3,4,
  8. Laura Tamblyn1,2,3,
  9. Amro Shehabeldin1,2,3,
  10. Eva Migon1,2,3,
  11. Andrew Wakeham1,2,
  12. Denis Bouchard1,2,
  13. Wen Chen Yeh1,2,3,
  14. Jane C. McGlade3,4,
  15. Pamela S. Ohashi2,3, and
  16. Razqallah Hakem1,2,3,5
  1. 1The Advanced Medical Discovery Institute (AMDI), 2Ontario Cancer Institute, and 3Department of Medical Biophysics, University of Toronto, Toronto, Ontario M5G 2C1, Canada; 4The Arthur and Sonia Labatt Brain Tumor Research Center, The Hospital for Sick Children, Toronto, Ontario M5G 1X8, Canada

Abstract

Defects in death receptor-mediated apoptosis have been linked to cancer and autoimmune disease in humans. The in vivo role of caspase 8, a component of this pathway, has eluded analysis in postnatal tissues because of the lack of an appropriate animal model. Targeted disruption of caspase 8 is lethal in utero. We generated mice with a targeted caspase 8 mutation that is restricted to the T-cell lineage. Despite normal thymocyte development in the absence of caspase 8, we observed a marked decrease in the number of peripheral T-cells and impaired T-cell response ex vivo to activation stimuli. caspase 8 ablation protected thymocytes and activated T-cells from CD95 ligand but not anti-CD3-induced apoptosis, or apoptosis activated by agents that are known to act through the mitochondria. caspase 8 mutant mice were unable to mount an immune response to viral infection, indicating that caspase 8 deletion in T-cells leads to immunodeficiency. These findings identify an essential, cell-stage-specific role for caspase 8 in T-cell homeostasis and T-cell-mediated immunity. This is consistent with the recent identification of caspase 8 mutations in human immunodeficiency.

Keywords

Footnotes

  • 5 Corresponding author.

  • E-MAIL rhakem{at}uhnres.utoronto.ca; FAX (416) 204-2277.

  • Article published online ahead of print. Article and publication date are at http://www.genesdev.org/cgi/doi/10.1101/gad.1063703.

    • Received December 2, 2002.
    • Accepted February 18, 2003.
| Table of Contents

Life Science Alliance